A phase III multicentre, randomized, double-blinded, placebo-controlled trial of SpironolacTOne and famciclovir in Progress Multiple Sclerosis: the STOP-MS trial

  • Broadley, Simon (Primary Chief Investigator (PCI))
  • Taylor, Bruce V. (Chief Investigator (CI))
  • Barnett, Michael Harry (Chief Investigator (CI))
  • Chataway, Jeremy (Chief Investigator (CI))
  • Parmar, Mahesh (Chief Investigator (CI))
  • Steinman, Lawrence (Chief Investigator (CI))
  • Tscharke, David C. (Chief Investigator (CI))
  • Kalincik, Tomas (Chief Investigator (CI))
  • Jokubaitis, Vilija (Chief Investigator (CI))
  • Smith, Corey (Chief Investigator (CI))
  • Sun, Jing (Chief Investigator (CI))
  • Campbell, Julie (Chief Investigator (CI))
  • Li, Vivien (Chief Investigator (CI))
  • Parnell, Grant P. (Chief Investigator (CI))
  • Ramanathan, Sudarshini (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date1/07/23 → 30/06/28